Wind-up and the NMDA receptor: from animal studies to humans
- 1 November 1994
- journal article
- Published by Wolters Kluwer Health
- Vol. 59 (2) , 157-8
- https://doi.org/10.1016/0304-3959(94)90067-1
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 17 references indexed in Scilit:
- The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801Acta Neuropathologica, 1994
- Response of chronic neuropathic pain syndromes to ketamine: a preliminary studyPain, 1994
- The NMDA antagonist memantine blocks pain behavior in a rat model of formalin-induced facial painPain, 1993
- Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathyBrain Research, 1993
- Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidencePain, 1993
- The NMDA-receptor antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humansPain, 1992
- Evidence of a role for NMDA receptors in pain perceptionEuropean Journal of Pharmacology, 1990
- A cure for wind up: NMDA receptor antagonists as potential analgesicsTrends in Pharmacological Sciences, 1990
- Evidence for involvement ofN-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the ratBrain Research, 1987
- Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following c fibre stimulation.Neuropharmacology, 1987